Global Endoparasiticide Market 2026 -
Players, Regions, Product Types, Application & Forecast Analysis
Global Endoparasiticide Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis
Chapter 1 Endoparasiticide Market Overview
1.1 Endoparasiticide Definition
1.2 Global Endoparasiticide Market Size Status and Outlook (2019-2032)
1.3 Global Endoparasiticide Market Size Comparison by Region (2019-2032)
1.4 Global Endoparasiticide Market Size Comparison by Type (2019-2032)
1.5 Global Endoparasiticide Market Size Comparison by Application (2019-2032)
1.6 Global Endoparasiticide Market Size Comparison by Sales Channel (2019-2032)
1.7 Endoparasiticide Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
1.7.6 US-Israel-Iran War Impacts
Chapter 2 Executive Summary
2.1 Global Endoparasiticide Market Snapshot
2.2 Global Endoparasiticide Market Volume & Revenue (2019-2025)
2.3 Global Endoparasiticide Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)
2.4 Global Endoparasiticide Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)
2.5 Global Endoparasiticide Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)
2.6 Global Endoparasiticide Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)
Chapter 3 Endoparasiticide Market Segment Analysis by Player
3.1 Global Endoparasiticide Sales and Market Share by Player (2023-2025)
3.2 Global Endoparasiticide Revenue and Market Share by Player (2023-2025)
3.3 Global Endoparasiticide Average Price by Player (2023-2025)
3.4 Players Competition Situation & Trends (2023-2025)
3.5 Conclusion of Segment by Player
Chapter 4 Endoparasiticide Market Segment Analysis by Type
4.1 Global Endoparasiticide Market by Type
4.1.1 Ear Tags
4.1.2 Tablets
4.1.3 Injectables
4.1.4 Feed Additives
4.2 Global Endoparasiticide Sales and Market Share by Type (2019-2025)
4.3 Global Endoparasiticide Revenue and Market Share by Type (2019-2025)
4.4 Global Endoparasiticide Average Price by Type (2019-2025)
4.5 Leading Players of Endoparasiticide by Type in 2025
4.6 Conclusion of Segment by Type
Chapter 5 Endoparasiticide Market Segment Analysis by Application
5.1 Global Endoparasiticide Market by Application
5.1.1 Veterinary Hospitals or Clinics
5.1.2 Animal Farms
5.1.3 Home Care Settings
5.2 Global Endoparasiticide Revenue and Market Share by Application (2019-2025)
5.3 Leading Consumers of Endoparasiticide by Application in 2025
5.4 Conclusion of Segment by Application
Chapter 6 Endoparasiticide Market Segment Analysis by Sales Channel
6.1 Global Endoparasiticide Market by Sales Channel
6.1.1 Global Endoparasiticide Market, by Direct Channel Market Analysis (2019-2032) (USD Million)
6.1.2 Global Endoparasiticide Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)
6.2 Global Endoparasiticide Revenue and Market Share by Sales Channel (2019-2025)
6.3 Leading Distributors/Dealers of Endoparasiticide by Sales Channel in 2025
6.4 Conclusion of Segment by Sales Channel
Chapter 7 Endoparasiticide Market Segment Analysis by Region
7.1 Global Endoparasiticide Market Size and CAGR by Region (2019-2032)
7.2 Global Endoparasiticide Sales and Market Share by Region (2019-2025)
7.3 Global Endoparasiticide Revenue and Market Share by Region (2019-2025)
7.4 North America
7.4.1 North America Market by Country
7.4.2 North America Endoparasiticide Market Share by Type
7.4.3 North America Endoparasiticide Market Share by Application
7.4.4 United States
7.4.5 Canada
7.4.6 Mexico
7.5 Europe
7.5.1 Europe Market by Country
7.5.2 Europe Endoparasiticide Market Share by Type
7.5.3 Europe Endoparasiticide Market Share by Application
7.5.4 Germany
7.5.5 United Kingdom
7.5.6 France
7.5.7 Italy
7.5.8 Russia
7.5.9 Spain
7.5.10 Benelux
7.5.11 Poland
7.5.12 Austria
7.5.13 Portugal
7.5.14 Rest of Europe
7.6 Asia-Pacific
7.6.1 Asia-Pacific Market by Country
7.6.2 Asia-Pacific Endoparasiticide Market Share by Type
7.6.3 Asia-Pacific Endoparasiticide Market Share by Application
7.6.4 China
7.6.5 Japan
7.6.6 Korea
7.6.7 India
7.6.8 Southeast Asia
7.6.9 Australia
7.6.10 Taiwan
7.6.11 Rest of Asia Pacific
7.7 South America
7.7.1 South America Market by Country
7.7.2 South America Endoparasiticide Market Share by Type
7.7.3 South America Endoparasiticide Market Share by Application
7.7.4 Brazil
7.7.5 Argentina
7.7.6 Colombia
7.7.7 Chile
7.7.8 Peru
7.7.9 Venezuela
7.7.10 Rest of South America
7.8 Middle East & Africa
7.8.1 Middle East & Africa Market by Country
7.8.2 Middle East & Africa Endoparasiticide Market Share by Type
7.8.3 Middle East & Africa Endoparasiticide Market Share by Application
7.8.4 UAE
7.8.5 Saudi Arabia
7.8.6 South Africa
7.8.7 Egypt
7.8.8 Nigeria
7.9.9 Rest of Middle East & Africa
7.9 Conclusion of Segment by Region
Chapter 8 Profile of Leading Endoparasiticide Players
8.1 Boehringer Ingelheim
8.1.1 Company Snapshot
8.1.2 Product/Service Offered
8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.1.4 Recent Developments
8.2 Elanco
8.2.1 Company Snapshot
8.2.2 Product/Service Offered
8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.2.4 Recent Developments
8.3 Zoetis
8.3.1 Company Snapshot
8.3.2 Product/Service Offered
8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.3.4 Recent Developments
8.4 Merck
8.4.1 Company Snapshot
8.4.2 Product/Service Offered
8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.4.4 Recent Developments
8.5 Virbac
8.5.1 Company Snapshot
8.5.2 Product/Service Offered
8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.5.4 Recent Developments
8.6 Novartis AG
8.6.1 Company Snapshot
8.6.2 Product/Service Offered
8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.6.4 Recent Developments
8.7 Ceva Sante Animlae
8.7.1 Company Snapshot
8.7.2 Product/Service Offered
8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.7.4 Recent Developments
8.8 Bayer AG
8.8.1 Company Snapshot
8.8.2 Product/Service Offered
8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.8.4 Recent Developments
8.9 Eli Lilly
8.9.1 Company Snapshot
8.9.2 Product/Service Offered
8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.9.4 Recent Developments
8.10 Vetoquinol
8.10.1 Company Snapshot
8.10.2 Product/Service Offered
8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.10.4 Recent Developments
Chapter 9 Upstream and Downstream Analysis of Endoparasiticide
9.1 Industrial Chain of Endoparasiticide
9.2 Upstream of Endoparasiticide
9.2.1 Raw Materials (If Applicable)
9.2.2 Manufacturing Cost Structure (If Applicable)
9.2.3 Manufacturing Process (If Applicable)
9.3 Downstream of Endoparasiticide
9.3.1 Leading Distributors/Dealers of Endoparasiticide
9.3.2 Leading Consumers of Endoparasiticide
Chapter 10. Global Endoparasiticide Market Industry Analysis
10.1. Porter's Five Forces Analysis
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Buyers/Consumers
10.1.3. Bargaining Power of Suppliers
10.1.4. Threat of Substitute Types
10.1.5. Intensity of Competitive Rivalry
10.2. Major Growth Avenues within Global Endoparasiticide Market
10.2.1. Product Types
10.2.2. Applications
10.2.3. Sales Channels
10.2.4. Country
10.3. Endoparasiticide Industry Ecosystem
10.4. Price Trend Analysis (If Applicable)
10.5. Buying Criteria (If Applicable)
10.6. Regulations (If Applicable)
Chapter 11 Development Trend of Endoparasiticide (2026-2032)
11.1 Global Endoparasiticide Market Size (Sales and Revenue) Forecast (2026-2032)
11.2 Global Endoparasiticide Market Size and CAGR Forecast by Region (2026-2032)
11.3 Global Endoparasiticide Market Size and CAGR Forecast by Type (2026-2032)
11.4 Global Endoparasiticide Market Size and CAGR Forecast by Application (2026-2032)
11.5 Global Endoparasiticide Market Size and CAGR Forecast by Sales Channel (2026-2032)
Chapter 12. Import - Export Analysis (If Applicable)
12.1 North America Endoparasiticide Import-Export (2019-2025)
12.2 Europe Endoparasiticide Import-Export (2019-2025)
12.3 Asia Pacific Endoparasiticide Import-Export (2019-2025)
12.4 South America Endoparasiticide Import-Export (2019-2025)
12.5 Middle East & Africa Endoparasiticide Import-Export (2019-2025)
Chapter 13. Demand-Supply Gap Analysis
13.1 North America Endoparasiticide Demand-Supply (2019-2025)
13.2 Europe Endoparasiticide Demand-Supply (2019-2025)
13.3 Asia Pacific Endoparasiticide Demand-Supply (2019-2025)
13.4 South America Endoparasiticide Demand-Supply (2019-2025)
13.5 Middle East & Africa Endoparasiticide Demand-Supply (2019-2025)
Chapter 14 Appendix
14.1 Research Methodology
14.2 Data Sources
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.